Статті в журналах з теми "Benralizumab"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Benralizumab".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Antoniu, S. A. "Benralizumab." Drugs of the Future 39, no. 7 (2014): 463. http://dx.doi.org/10.1358/dof.2014.039.07.2156125.
Повний текст джерелаZhuravleva, M. V., S. N. Avdeev, Yu V. Gagarina, and T. V. Marin. "Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings." FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15, no. 2 (July 27, 2022): 175–86. http://dx.doi.org/10.17749/2070-4909/farmakoekonomika.2022.143.
Повний текст джерелаBourdin, Arnaud, Don Husereau, Nicolas Molinari, Sarowar Golam, Mohd Kashif Siddiqui, Leandro Lindner, and Xiao Xu. "Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review." European Respiratory Journal 52, no. 5 (October 11, 2018): 1801393. http://dx.doi.org/10.1183/13993003.01393-2018.
Повний текст джерелаAndo, Koichi, Akihiko Tanaka, and Hironori Sagara. "Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review." International Journal of Molecular Sciences 21, no. 3 (January 30, 2020): 889. http://dx.doi.org/10.3390/ijms21030889.
Повний текст джерелаBleecker, Eugene R., Michael E. Wechsler, J. Mark FitzGerald, Andrew Menzies-Gow, Yanping Wu, Ian Hirsch, Mitchell Goldman, Paul Newbold, and James G. Zangrilli. "Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma." European Respiratory Journal 52, no. 4 (August 23, 2018): 1800936. http://dx.doi.org/10.1183/13993003.00936-2018.
Повний текст джерелаYamada, Hideyasu, Masayuki Nakajima, Masashi Matsuyama, Yuko Morishima, Naoki Arai, Norihito Hida, Taisuke Nakaizumi, et al. "Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma." PLOS ONE 16, no. 3 (March 11, 2021): e0248305. http://dx.doi.org/10.1371/journal.pone.0248305.
Повний текст джерелаTitova, Olga N., Natalia A. Kuzubova, Daria B. Sklyarova, and Maria A. Petrova. "The effectiveness of benralizumab in the treatment of the eosinophilic phenotype of severe asthma in real clinical practice." PULMONOLOGIYA 31, no. 5 (October 20, 2021): 628–34. http://dx.doi.org/10.18093/0869-0189-2021-31-5-628-634.
Повний текст джерелаTsurumaki, Matsuyama, Ezawa, Koga, Yatomi, Aoki-Saito, Chikamatsu, and Hisada. "Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis." Medicina 55, no. 7 (July 3, 2019): 336. http://dx.doi.org/10.3390/medicina55070336.
Повний текст джерелаNedogoda, Sergey Vladimirovich, Alla Sergeevna Salasyuk, Irina Nikolaevna Barykina, Victoria Olegovna Smirnova та Maksim Yurevich Frolov. "Сost of the Biologacal Therapy for Severe Brochcial Asthma Treatment at Inpatient and Day Care Setting". Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор), № 1 (39) (1 травня 2020): 61–69. http://dx.doi.org/10.31556/2219-0678.2020.39.1.061-069.
Повний текст джерелаMarkham, A. "Benralizumab: First Global Approval." Drugs 78, no. 4 (February 20, 2018): 505–11. http://dx.doi.org/10.1007/s40265-018-0876-8.
Повний текст джерелаLombardo, Nicola, Corrado Pelaia, Marco Ciriolo, Marcello Della Corte, Giovanna Piazzetta, Nadia Lobello, Pasquale Viola, and Girolamo Pelaia. "Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma." International Journal of Immunopathology and Pharmacology 34 (January 2020): 205873842095085. http://dx.doi.org/10.1177/2058738420950851.
Повний текст джерелаLászló, Nimród, Hédy Katalin Sárközy, Cristina Alexandra Man, Edith Simona Ianoși, Botond Mátyás, Bianca Emilia Ciurba, Corina Mărginean, and Gabriela Jimborean. "The Benefit of Benralizumab Monoclonal Antibody Treatment for Severe Eosinophilic Asthma in a Case Series (Pulmonology Clinic Târgu Mureș, Romania)." Journal of Interdisciplinary Medicine 6, no. 3 (September 1, 2021): 157–61. http://dx.doi.org/10.2478/jim-2021-0030.
Повний текст джерелаPintea, Irena, Ioana Adriana Muntean, Carmen Teodora Dobrican, Nicolae Miron, and Diana Deleanu. "Off-Label Benralizumab in Severe Non-Necrotizing Eosinophilic Vasculitis following Critical COVID-19 Disease and in DRESS." Journal of Clinical Medicine 11, no. 22 (November 9, 2022): 6642. http://dx.doi.org/10.3390/jcm11226642.
Повний текст джерелаPelaia, Corrado, Claudia Crimi, Santi Nolasco, Giovanna Elisiana Carpagnano, Raffaele Brancaccio, Enrico Buonamico, Raffaele Campisi, et al. "Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy." Biomedicines 9, no. 12 (December 3, 2021): 1822. http://dx.doi.org/10.3390/biomedicines9121822.
Повний текст джерелаCañas, José A., Marcela Valverde-Monge, José M. Rodrigo-Muñoz, Beatriz Sastre, Marta Gil-Martínez, Raquel García-Latorre, Manuel J. Rial, et al. "Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma." Journal of Personalized Medicine 11, no. 2 (January 28, 2021): 76. http://dx.doi.org/10.3390/jpm11020076.
Повний текст джерелаVitale, Carolina, Angelantonio Maglio, Corrado Pelaia, Maria D’Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, and Alessandro Vatrella. "Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting." Journal of Clinical Medicine 12, no. 3 (January 27, 2023): 985. http://dx.doi.org/10.3390/jcm12030985.
Повний текст джерелаBernstein, Jonathan A., Umesh Singh, Marepalli B. Rao, Karen Berendts, Xiang Zhang, and Diya Mutasim. "Benralizumab for Chronic Spontaneous Urticaria." New England Journal of Medicine 383, no. 14 (October 1, 2020): 1389–91. http://dx.doi.org/10.1056/nejmc2016395.
Повний текст джерелаCooke, W. Donald, and Abigail Tarr Cooke. "Eosinophilic cystitis treatment with benralizumab." Journal of Allergy and Clinical Immunology 145, no. 2 (February 2020): AB67. http://dx.doi.org/10.1016/j.jaci.2019.12.734.
Повний текст джерелаMurray, Toby, Ben Haagsma, and Andrew Chetwood. "Non-infective cystitis secondary to benralizumab immunotherapy." BMJ Case Reports 15, no. 1 (January 2022): e244733. http://dx.doi.org/10.1136/bcr-2021-244733.
Повний текст джерелаSereda, V. P., D. A. Svirido, M. V. Komarov, Zhanna A. Mironova, and M. A. Nyoma. "Experience of using benralizumab in the treatment of patients with severe asthma in the clinical practice of pulmonologists in Saint-Petersburg." PULMONOLOGIYA 32, no. 5 (September 21, 2022): 670–77. http://dx.doi.org/10.18093/0869-0189-2022-32-5-670-677.
Повний текст джерелаVantaggiato, Lorenza, Paolo Cameli, Laura Bergantini, Miriana d’Alessandro, Enxhi Shaba, Alfonso Carleo, Fabrizio Di Giuseppe, et al. "Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment." Biomedicines 10, no. 4 (March 24, 2022): 761. http://dx.doi.org/10.3390/biomedicines10040761.
Повний текст джерелаJauhiainen, Alexandra, Lieke E. J. M. Scheepers, Anne L. Fuhlbrigge, Tim Harrison, James Zangrilli, Esther Garcia Gil, Per Gustafson, Malin Fagerås, and Carla A. Da Silva. "Impact of season and geography on CompEx Asthma: a composite end-point for exacerbations." ERJ Open Research 6, no. 4 (October 2020): 00246–2020. http://dx.doi.org/10.1183/23120541.00246-2020.
Повний текст джерелаLacouture, Mario E., Alexander Pan, George Dranitsaris, Ucalene Harris, Sarat Chandarlapaty, Chau T. Dang, Devika Gajria, et al. "Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 12100. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.12100.
Повний текст джерелаLacouture, Mario E., Alexander Pan, George Dranitsaris, Ucalene Harris, Sarat Chandarlapaty, Chau T. Dang, Devika Gajria, et al. "Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 12100. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.12100.
Повний текст джерелаKrysanov, I. S., V. S. Krysanova, and V. Yu Ermakova. "Th e clinical-economic analysis of Dupilumab in severe asthma." Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, no. 5 (February 14, 2021): 15–26. http://dx.doi.org/10.37489/2588-0519-2020-5-15-26.
Повний текст джерелаMiralles-López, Juan Carlos, Rubén Andújar-Espinosa, Francisco Javier Bravo-Gutiérrez, Manuel Castilla-Martínez, Isabel Flores-Martín, María Loreto Alemany-Francés, Manuel José Pajarón-Fernández, et al. "Analysis of response of severe eosinophilic asthmatic patients to benralizumab." Allergologia et Immunopathologia 50, no. 6 (November 1, 2022): 163–68. http://dx.doi.org/10.15586/aei.v50i6.704.
Повний текст джерелаShimizu, Hideyasu, Masamichi Hayashi, Hisayuki Kato, Mitsuru Nakagawa, Kazuyoshi Imaizumi, and Mitsushi Okazawa. "IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma." International Journal of Molecular Sciences 22, no. 20 (October 18, 2021): 11209. http://dx.doi.org/10.3390/ijms222011209.
Повний текст джерелаLaorden, Daniel, David Romero, and Javier Domínguez-Ortega. "Benralizumab in eosinophilic granulomatosis with polyangiitis." Medicina Clínica (English Edition) 158, no. 9 (May 2022): 441–42. http://dx.doi.org/10.1016/j.medcle.2021.07.018.
Повний текст джерелаSugino, Keishi, Hirotaka Ono, Akira Hebisawa, and Eiyasu Tsuboi. "Eosinophilic bronchiolitis successfully treated with benralizumab." BMJ Case Reports 14, no. 10 (October 2021): e246058. http://dx.doi.org/10.1136/bcr-2021-246058.
Повний текст джерелаMatera, M. G., P. Rogliani, L. Calzetta, G. W. Canonica, and M. Cazzola. "Benralizumab for the treatment of asthma." Drugs of Today 53, no. 12 (2017): 633. http://dx.doi.org/10.1358/dot.2017.53.12.2736670.
Повний текст джерелаKuang, Fei Li, Fanny Legrand, Michelle Makiya, JeanAnne Ware, Lauren Wetzler, Thomas Brown, Tamika Magee, et al. "Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome." New England Journal of Medicine 380, no. 14 (April 4, 2019): 1336–46. http://dx.doi.org/10.1056/nejmoa1812185.
Повний текст джерелаSaco, Tara Vinyette, Amber N. Pepper, and Richard F. Lockey. "Benralizumab for the treatment of asthma." Expert Review of Clinical Immunology 13, no. 5 (April 19, 2017): 405–13. http://dx.doi.org/10.1080/1744666x.2017.1316194.
Повний текст джерелаHussar, Daniel A., and Justin George. "Erenumab-aooe, Benralizumab, and Tezacaftor/ivacaftor." Journal of the American Pharmacists Association 58, no. 5 (September 2018): 579–82. http://dx.doi.org/10.1016/j.japh.2018.07.006.
Повний текст джерелаGriscti Soler, Daniel, Alessandra Bennici, Silvia Brunetto, Sebastiano Gangemi, and Luisa Ricciardi. "Benralizumab in the management of rare primary eosinophilic lung diseases." Allergy and Asthma Proceedings 43, no. 6 (November 1, 2022): 494–500. http://dx.doi.org/10.2500/aap.2022.43.220056.
Повний текст джерелаWechsler, M., P. A. Merkel, S. Necander, L. Börjesson Sjö, E. A. Duncan, N. Makulova, G. D’angelo та ін. "AB0619 Rationale and Design of the 52-week, Randomized, Phase 3, Head-to-Head MANDARA Study to Evaluate the Efficacy and Safety of Benralizumab, a Humanized, Anti-interleukin–5 Receptor α Monoclonal Antibody in Refractory or Relapsing Eosinophilic Granulomatosis with Polyangiitis". Annals of the Rheumatic Diseases 81, Suppl 1 (23 травня 2022): 1435.2–1436. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2075.
Повний текст джерелаIgnatova, G. L., V. N. Antonov, E. V. Blinova, I. V. Grebneva, and E. V. Sheklanova. "New therapy options for patients with eosinophilic type of severe bronchial asthma." Medical Council, no. 21 (January 28, 2020): 111–16. http://dx.doi.org/10.21518/2079-701x-2019-21-111-116.
Повний текст джерелаLeuppi, Jörg D., Peter Schmid-Grendelmeier, Thomas Rothe, Christophe von Garnier, Hans-Uwe Simon, Claudio Schuoler, Gunther Pendl, and Markus Solèr. "Benralizumab: Der IL-5-Rezeptor als Ziel bei schwerem eosinophilem Asthma." Praxis 108, no. 7 (May 2019): 469–76. http://dx.doi.org/10.1024/1661-8157/a003222.
Повний текст джерелаLeuppi, Jörg D., Peter Schmid-Grendelmeier, Thomas Rothe, Christophe von Garnier, Hans-Uwe Simon, Claudio Schuoler, Gunther Pendl, and Markus Solèr. "Benralizumab: Cibler le récepteur de l’IL-5 dans l’asthme sévère éosinophile." Praxis 108, no. 7 (May 2019): 1–8. http://dx.doi.org/10.1024/1661-8157/a003250.
Повний текст джерелаMenzella, Francesco, Mirco Lusuardi, Carla Galeone, Nicola Facciolongo, and Luigi Zucchi. "The clinical profile of benralizumab in the management of severe eosinophilic asthma." Therapeutic Advances in Respiratory Disease 10, no. 6 (September 19, 2016): 534–48. http://dx.doi.org/10.1177/1753465816667659.
Повний текст джерелаNolasco, Santi, Raffaele Campisi, Rossella Intravaia, Morena Porto, Corrado Pelaia, Nunzio Crimi, and Claudia Crimi. "Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use." F1000Research 9 (June 23, 2020): 637. http://dx.doi.org/10.12688/f1000research.24603.1.
Повний текст джерелаNolasco, Santi, Raffaele Campisi, Rossella Intravaia, Morena Porto, Corrado Pelaia, Nunzio Crimi, and Claudia Crimi. "Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use." F1000Research 9 (July 23, 2020): 637. http://dx.doi.org/10.12688/f1000research.24603.2.
Повний текст джерелаMorimoto, Hiroki, Kensuke Fukuchi, Yasuaki Ogura, Masaki Ohtsuka, and Yoshiki Tokura. "Development of lichen planus following benralizumab treatment." European Journal of Dermatology 31, no. 2 (April 2021): 261–62. http://dx.doi.org/10.1684/ejd.2021.3995.
Повний текст джерелаEngler, D. "M271 SEVERE EOSINOPHILIC CYSTITIS CONTROLLED WITH BENRALIZUMAB." Annals of Allergy, Asthma & Immunology 127, no. 5 (November 2021): S122. http://dx.doi.org/10.1016/j.anai.2021.08.388.
Повний текст джерелаCushen, Breda, and Andrew Menzies-Gow. "Benralizumab: an updated treatment of eosinophilic asthma." Expert Review of Respiratory Medicine 14, no. 5 (March 17, 2020): 435–44. http://dx.doi.org/10.1080/17476348.2020.1739526.
Повний текст джерелаMishra, Ajay Kumar, Kamal Kant Sahu, and Atem James. "Disseminated herpes zoster following treatment with benralizumab." Clinical Respiratory Journal 13, no. 3 (February 17, 2019): 189–91. http://dx.doi.org/10.1111/crj.12998.
Повний текст джерелаCriner, Gerard J., Bartolome R. Celli, Christopher E. Brightling, Alvar Agusti, Alberto Papi, Dave Singh, Don D. Sin, et al. "Benralizumab for the Prevention of COPD Exacerbations." New England Journal of Medicine 381, no. 11 (September 12, 2019): 1023–34. http://dx.doi.org/10.1056/nejmoa1905248.
Повний текст джерелаFabbri, Leonardo M. "Benralizumab: for asthma, not yet for COPD." Lancet Respiratory Medicine 2, no. 11 (November 2014): 862–63. http://dx.doi.org/10.1016/s2213-2600(14)70225-5.
Повний текст джерелаDagher, Rania, Varsha Kumar, Alan M. Copenhaver, Sandra Gallagher, Mahboobe Ghaedi, Jonathan Boyd, Paul Newbold, Alison A. Humbles, and Roland Kolbeck. "Novel mechanisms of action contributing to Benralizumab's potent anti-eosinophilic activity." European Respiratory Journal, July 21, 2021, 2004306. http://dx.doi.org/10.1183/13993003.04306-2020.
Повний текст джерела"Benralizumab." Reactions Weekly 1914, no. 1 (July 2022): 126. http://dx.doi.org/10.1007/s40278-022-18712-0.
Повний текст джерела"Benralizumab." Reactions Weekly 1895, no. 1 (February 2022): 95. http://dx.doi.org/10.1007/s40278-022-10520-1.
Повний текст джерела